Traditional Chinese medicine for treating pancreatic cancer

Abstract

The invention discloses a traditional Chinese medicine for treating pancreatic cancer. The traditional Chinese medicine is prepared from the following medicinal materials in parts by weight, 10-20 parts of ovateleaf holly bark, 5-12 parts of hedysarum polybotrys, 12-25 parts of rhizoma chuanxiong, 9-27 parts of white atractylodes rhizome, 3-9 parts of hog brake, 12-25 parts of common yam rhizome, 4-20 parts of hypericum ascyron, 5-12 parts of golden larch bark, 10-19 parts of semen strychni pulveratum, 3-9 parts of persimmon calyx, 6-18 parts of amorphophallus virosus, 4-12 parts of gypenoside, 8-19 parts of rhizoma cimicifugae, 5-20 parts of loofah sponges and 9-25 parts of tortoise. The traditional Chinese medicine can be individually used, can also be matched with radiotherapy and chemotherapy and has the functions of reducing a tumor in a short period, effectively controlling metastasis and diffusion of cancer cells, inhibiting growth of the cancer cells, avoiding side effects, treating and resisting the cancer, enhancing body immunity, relieving pain of a patient, stabilizing illness conditions, prolonging lifetime, increasing the proportion of clinical cure patients, preventing residual cancer cells from coming back and greatly reducing recurrence and metastasis.

Description

technical field [0001] The invention relates to a traditional Chinese medicine for treating pancreatic cancer, which belongs to the technical field of medicine. Background technique [0002] Pancreatic cancer is a common pancreatic tumor. It is a highly malignant tumor of the digestive tract that is difficult to diagnose and treat. About 90% of it is ductal adenocarcinoma originating from the ductal epithelium. Its morbidity and mortality have increased in recent years. significantly increased. The 5-year survival rate is <1%, and it is one of the malignant tumors with the worst prognosis. The early diagnosis rate of pancreatic cancer is not high, the surgical mortality rate is high, and the cure rate is very low. The incidence of this disease is higher in men than in women. The ratio is 1.5-2:1, male patients are far more common than premenopausal women, and the incidence rate of postmenopausal women is similar to that of men. More common in 40-70 years old, more men t...

AI Technical Summary

Problems solved by technology

However, the methods of surgery and chemotherapy are flawed, because the early diagnosis of pancreatic cancer is difficult, the rate of surgical resection is low, and the five-year survival rate after surgery is also low; chemotherapy can effectively damage cancer cells, but at the same time it can kill normal cells and cause The patient's immune function is suppressed, and more complications occur, causing great damage to the patient's body